FGF19 Regulates Cell Proliferation, Glucose and Bile Acid Metabolism via FGFR4-Dependent and Independent Pathways

被引:177
作者
Wu, Ai-Luen [1 ]
Coulter, Sally [2 ]
Liddle, Christopher [2 ]
Wong, Anne [3 ]
Eastham-Anderson, Jeffrey [4 ]
French, Dorothy M. [4 ]
Peterson, Andrew S. [1 ]
Sonoda, Junichiro [1 ]
机构
[1] Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA
[2] Univ Sydney, Westmead Millennium Inst, Storr Liver Unit, Sydney, NSW 2006, Australia
[3] Genentech Inc, Dept Assay & Automat Technol, San Francisco, CA 94080 USA
[4] Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA
基金
英国医学研究理事会;
关键词
FIBROBLAST-GROWTH-FACTOR; TRANSGENIC MICE; HEPATOCELLULAR-CARCINOMA; BETA-KLOTHO; MOUSE MODEL; FGFR4; FIBROBLAST-GROWTH-FACTOR-19; EXPRESSION; GENE; FXR;
D O I
10.1371/journal.pone.0017868
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Fibroblast growth factor 19 (FGF19) is a hormone-like protein that regulates carbohydrate, lipid and bile acid metabolism. At supra-physiological doses, FGF19 also increases hepatocyte proliferation and induces hepatocellular carcinogenesis in mice. Much of FGF19 activity is attributed to the activation of the liver enriched FGF Receptor 4 (FGFR4), although FGF19 can activate other FGFRs in vitro in the presence of the coreceptor beta Klotho (KLB). In this report, we investigate the role of FGFR4 in mediating FGF19 activity by using Fgfr4 deficient mice as well as a variant of FGF19 protein (FGF19v) which is specifically impaired in activating FGFR4. Our results demonstrate that FGFR4 activation mediates the induction of hepatocyte proliferation and the suppression of bile acid biosynthesis by FGF19, but is not essential for FGF19 to improve glucose and lipid metabolism in high fat diet fed mice as well as in leptin-deficient ob/ob mice. Thus, FGF19 acts through multiple receptor pathways to elicit pleiotropic effects in regulating nutrient metabolism and cell proliferation.
引用
收藏
页数:11
相关论文
共 36 条
[1]   The FGF family: biology, pathophysiology and therapy [J].
Beenken, Andrew ;
Mohammadi, Moosa .
NATURE REVIEWS DRUG DISCOVERY, 2009, 8 (03) :235-253
[2]   Identification of a hormonal basis for gallbladder filling [J].
Choi, Mihwa ;
Moschetta, Antonio ;
Bookout, Angie L. ;
Peng, Li ;
Umetani, Michihisa ;
Holmstrom, Sam R. ;
Suino-Powell, Kelly ;
Xu, H. Eric ;
Richardson, James A. ;
Gerard, Robert D. ;
Mangelsdorf, David J. ;
Kliewer, Steven A. .
NATURE MEDICINE, 2006, 12 (11) :1253-1255
[3]   Raf and fibroblast growth factor phosphorylate Elk1 and activate the serum response element of the immediate early gene pip92 by mitogen-activated protein kinase-independent as well as -dependent signaling pathways [J].
Chung, KC ;
Gomes, I ;
Wang, DH ;
Lau, LF ;
Rosner, MR .
MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (04) :2272-2281
[4]   Fibroblast Growth Factor 21 Corrects Obesity in Mice [J].
Coskun, Tamer ;
Bina, Holly A. ;
Schneider, Michael A. ;
Dunbar, James D. ;
Hu, Charlie C. ;
Chen, Yanyun ;
Moller, David E. ;
Kharitonenkov, Alexei .
ENDOCRINOLOGY, 2008, 149 (12) :6018-6027
[5]   Targeting FGF19 inhibits tumor growth in colon cancer xenograft and FGF19 transgenic hepatocellular carcinoma models [J].
Desnoyers, Lr ;
Pai, R. ;
Ferrando, Re ;
Hotzel, K. ;
Le, T. ;
Ross, J. ;
Carano, R. ;
D'Souza, A. ;
Qing, J. ;
Mohtashemi, I. ;
Ashkenazi, A. ;
French, Dm .
ONCOGENE, 2008, 27 (01) :85-97
[6]   Fibroblast growth factor 19 increases metabolic rate I and reverses dietary and leptlin-deficient diabetes [J].
Fu, L ;
John, LM ;
Adams, SH ;
Yu, XX ;
Tomlinson, E ;
Renz, M ;
Williams, PM ;
Soriano, R ;
Corpuz, R ;
Moffat, B ;
Vandlen, R ;
Simmons, L ;
Foster, J ;
Stephan, JP ;
Tsai, SP ;
Stewart, TA .
ENDOCRINOLOGY, 2004, 145 (06) :2594-2603
[7]   Antidiabetic Effects of IGFBP2, a Leptin-Regulated Gene [J].
Hedbacker, Kristina ;
Birsoy, Kivanc ;
Wysocki, Robert W. ;
Asilmaz, Esra ;
Ahima, Rexford S. ;
Farooqi, I. Sadaf ;
Friedman, Jeffrey M. .
CELL METABOLISM, 2010, 11 (01) :11-22
[8]   Definition of a novel growth factor-dependent signal cascade for the suppression of bile acid biosynthesis [J].
Holt, JA ;
Luo, GZ ;
Billin, AN ;
Bisi, J ;
McNeill, YY ;
Kozarsky, KF ;
Donahee, M ;
Wang, DY ;
Mansfield, TA ;
Kliewer, SA ;
Goodwin, B ;
Jones, SA .
GENES & DEVELOPMENT, 2003, 17 (13) :1581-1591
[9]   FGFR4 prevents hyperlipidemia and insulin resistance but underlies high-fat diet-induced fatty liver [J].
Huang, Xinqiang ;
Yang, Chaofeng ;
Luo, Yongde ;
Jin, Chengliu ;
Wang, Fen ;
McKeehan, Wallace L. .
DIABETES, 2007, 56 (10) :2501-2510
[10]   Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis [J].
Inagaki, T ;
Choi, M ;
Moschetta, A ;
Peng, L ;
Cummins, CL ;
McDonald, JG ;
Luo, G ;
Jones, SA ;
Goodwin, B ;
Richardson, JA ;
Gerard, RD ;
Repa, JJ ;
Mangelsdorf, DJ ;
Kliewer, SA .
CELL METABOLISM, 2005, 2 (04) :217-225